Related Experiment Video
Updated: May 20, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
[Infective fungal endocarditis in patients with no previous cardiac disease]
L Marcano Sanz1, A Naranjo Ugalde, A González Guillén
1Servicio de Cirugía Cardiovascular, Cardiocentro Pediátrico William Soler, La Habana, Cuba. resccv@infomed.sld.cu
Abstract:
Infective endocarditis is a serious and uncommon condition affecting the endocardium. Less than 10% of these cases are of fungal origin. A growing number of individuals are at high risk, due to insertion of central venous catheters, total parenteral nutrition and prolonged exposure to broad-spectrum antibiotics, even without previous heart diseases. We retrospectively analysed the records of six children with Candida endocarditis, reviewing the comorbidities, clinical outcome, and treatment. The antifungal agents used were amphotericin B, 5-fluorocytosine and fluconazole. Patients underwent surgical excision of vegetation, five tricuspid valve repairs and one mitral valve replacement. There were no hospital deaths, and one child needed a new valvuloplasty one year later. The mean follow up was five years, and all have good valvular function without recurrent endocarditis. A combination of synergistic long-term antifungal treatment and early surgical intervention is recommended.
Insights
Fungal endocarditis, particularly Candida endocarditis, is rare but increasingly seen in at-risk individuals. Early surgical intervention combined with long-term antifungal therapy leads to excellent outcomes in children.
Area of Science:
- Infectious Diseases
- Cardiology
- Mycology
Context:
- Infective endocarditis is a severe condition affecting heart valves.
- Fungal endocarditis accounts for less than 10% of cases.
- Risk factors include central venous catheters, parenteral nutrition, and broad-spectrum antibiotics.
Purpose:
- To review comorbidities, clinical outcomes, and treatment strategies for pediatric Candida endocarditis.
- To evaluate the effectiveness of antifungal agents and surgical interventions.
Summary:
- Retrospective analysis of six children with Candida endocarditis.
- Treatments included amphotericin B, 5-fluorocytosine, and fluconazole.
- Surgical interventions involved vegetation excision, valve repair, and valve replacement.
Impact:
- No hospital deaths were recorded.
- One patient required a subsequent valvuloplasty.
- Mean follow-up of five years showed good valvular function and no recurrent infections.
- Recommends synergistic long-term antifungal treatment and early surgical intervention.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis I: Introduction
